Cargando…
3-month daily rifampicin and isoniazid compared to 6- or 9-month isoniazid for treating latent tuberculosis infection in children and adolescents less than 15 years of age: an updated systematic review
Treatment of latent tuberculosis infection in children with a 3-month daily rifampicin and isoniazid regimen is safe with better compliance, adherence and completion rate than a 6- or 9-month isoniazid monotherapy http://ow.ly/x28Z30jDfCE
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Respiratory Society
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095703/ https://www.ncbi.nlm.nih.gov/pubmed/29748305 http://dx.doi.org/10.1183/13993003.00395-2018 |
| _version_ | 1783347985300586496 |
|---|---|
| author | Assefa, Yibeltal Assefa, Yalemzewod Woldeyohannes, Solomon Hamada, Yohhei Getahun, Haileyesus |
| author_facet | Assefa, Yibeltal Assefa, Yalemzewod Woldeyohannes, Solomon Hamada, Yohhei Getahun, Haileyesus |
| author_sort | Assefa, Yibeltal |
| collection | PubMed |
| description | Treatment of latent tuberculosis infection in children with a 3-month daily rifampicin and isoniazid regimen is safe with better compliance, adherence and completion rate than a 6- or 9-month isoniazid monotherapy http://ow.ly/x28Z30jDfCE |
| format | Online Article Text |
| id | pubmed-6095703 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | European Respiratory Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-60957032018-08-20 3-month daily rifampicin and isoniazid compared to 6- or 9-month isoniazid for treating latent tuberculosis infection in children and adolescents less than 15 years of age: an updated systematic review Assefa, Yibeltal Assefa, Yalemzewod Woldeyohannes, Solomon Hamada, Yohhei Getahun, Haileyesus Eur Respir J Agora Treatment of latent tuberculosis infection in children with a 3-month daily rifampicin and isoniazid regimen is safe with better compliance, adherence and completion rate than a 6- or 9-month isoniazid monotherapy http://ow.ly/x28Z30jDfCE European Respiratory Society 2018-07-12 /pmc/articles/PMC6095703/ /pubmed/29748305 http://dx.doi.org/10.1183/13993003.00395-2018 Text en Copyright ©ERS 2018 http://creativecommons.org/licenses/by-nc/4.0/ This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. |
| spellingShingle | Agora Assefa, Yibeltal Assefa, Yalemzewod Woldeyohannes, Solomon Hamada, Yohhei Getahun, Haileyesus 3-month daily rifampicin and isoniazid compared to 6- or 9-month isoniazid for treating latent tuberculosis infection in children and adolescents less than 15 years of age: an updated systematic review |
| title | 3-month daily rifampicin and isoniazid compared to 6- or 9-month isoniazid for treating latent tuberculosis infection in children and adolescents less than 15 years of age: an updated systematic review |
| title_full | 3-month daily rifampicin and isoniazid compared to 6- or 9-month isoniazid for treating latent tuberculosis infection in children and adolescents less than 15 years of age: an updated systematic review |
| title_fullStr | 3-month daily rifampicin and isoniazid compared to 6- or 9-month isoniazid for treating latent tuberculosis infection in children and adolescents less than 15 years of age: an updated systematic review |
| title_full_unstemmed | 3-month daily rifampicin and isoniazid compared to 6- or 9-month isoniazid for treating latent tuberculosis infection in children and adolescents less than 15 years of age: an updated systematic review |
| title_short | 3-month daily rifampicin and isoniazid compared to 6- or 9-month isoniazid for treating latent tuberculosis infection in children and adolescents less than 15 years of age: an updated systematic review |
| title_sort | 3-month daily rifampicin and isoniazid compared to 6- or 9-month isoniazid for treating latent tuberculosis infection in children and adolescents less than 15 years of age: an updated systematic review |
| topic | Agora |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095703/ https://www.ncbi.nlm.nih.gov/pubmed/29748305 http://dx.doi.org/10.1183/13993003.00395-2018 |
| work_keys_str_mv | AT assefayibeltal 3monthdailyrifampicinandisoniazidcomparedto6or9monthisoniazidfortreatinglatenttuberculosisinfectioninchildrenandadolescentslessthan15yearsofageanupdatedsystematicreview AT assefayalemzewod 3monthdailyrifampicinandisoniazidcomparedto6or9monthisoniazidfortreatinglatenttuberculosisinfectioninchildrenandadolescentslessthan15yearsofageanupdatedsystematicreview AT woldeyohannessolomon 3monthdailyrifampicinandisoniazidcomparedto6or9monthisoniazidfortreatinglatenttuberculosisinfectioninchildrenandadolescentslessthan15yearsofageanupdatedsystematicreview AT hamadayohhei 3monthdailyrifampicinandisoniazidcomparedto6or9monthisoniazidfortreatinglatenttuberculosisinfectioninchildrenandadolescentslessthan15yearsofageanupdatedsystematicreview AT getahunhaileyesus 3monthdailyrifampicinandisoniazidcomparedto6or9monthisoniazidfortreatinglatenttuberculosisinfectioninchildrenandadolescentslessthan15yearsofageanupdatedsystematicreview |